Federated Hermes, Inc. Dice Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 08, 2023	BUY	$26.05 - $32.31 $2.81 Million - $3.48 Million	107,847 Added 263041.47%	107,888 $3.09 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $810 - $1,731	41 New	41 $1,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.